CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-04 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 62,788 | ||
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $565.78 | $113K | 49,813 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $567.17 | $45K | 49,733 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −197 | $568.37 | $112K | 49,536 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −843 | $569.18 | $480K | 48,693 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,621 | $570.28 | $2.1M | 45,072 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,197 | $571.22 | $1.8M | 41,875 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,362 | $571.95 | $779K | 40,513 |
| 2026-05-01 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 72,288 | ||
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −262 | $569.24 | $149K | 28,614 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −484 | $570.19 | $276K | 28,130 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,940 | $571.23 | $1.7M | 25,190 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −3,034 | $572.00 | $1.7M | 22,156 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −880 | $573.00 | $504K | 21,276 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −887 | $574.07 | $509K | 20,389 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −273 | $574.96 | $157K | 20,116 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −486 | $576.24 | $280K | 19,630 |
| 2026-04-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −336 | $577.24 | $194K | 19,294 |
Page 113 of 121 · 2,404 trades